Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Apply
Olvimulogene Nanivacirepvec & Platinum-doublet
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step